Nordson MARCH Company Profile

News Articles [ 47 Associated News Articles listed on BioPortfolio]

FlexVIA Plasma System from Nordson MARCH Wins New Product Introduction Award for Surface Treatment of Flexible PCB Materials

Nordson MARCH, a global leader in plasma processing technology, received the New Product Introduction (NPI) Award for its FlexVIA™ Plasma System, a completely self-contai...

FlexVIA Plasma System from Nordson MARCH Wins Innovation Award for Plasma Surface Treatment of Flexible PCB Materials

System recognized as a cost-effective and environmentally friendly vacuum plasma solution, used during printed circuit board manufacturing Nordson MAR...

Nordson MARCH Introduces Fully Automated Plasma Treatment System that Lowers the Handling Risk to Sensitive Substrate Materials

Nordson MARCH, a global leader in plasma processing technology, introduces the new FasTRAK™ Plasma System, a fully-automated, high-throughput, vacuum plasma treatment sys...

Nordson sees "excellent" Q4 earnings ahead, Q3 beats estimates

Nordson (NASDAQ:NDSN), which makes precision dispensing machines used in manufacturing of consumer goods, late Monday said it expects to achieve a "record" full-year performance.  For the f...

New Nordson MARCH FlexVIA System Offers Cost-Effective and Easy-to-Use Plasma Treatment for Flexible PCB Materials

Nordson MARCH, a global leader in plasma processing technology, announces its new FlexVIA™ Plasma System, a completely self-contained vacuum plasma system designed for ma...

Nordson Corporation Announces Earnings Release and Webcast for Third Quarter Fiscal Year 2012

WESTLAKE, Ohio, July 31, 2012 (GLOBE NEWSWIRE) -- Nordson Corporation (Nasdaq:NDSN) today announced it will release third quarter fiscal year 2012 earnings on Monday, August 20, 2012 after the close...

Nordson Corporation Announces Earnings Release and Webcast for First Quarter Fiscal Year 2013

WESTLAKE, Ohio, Feb. 1, 2013 (GLOBE NEWSWIRE) -- Nordson Corporation (Nasdaq:NDSN) today announced it will release first quarter fiscal year 2013 earnings on Thursday, February 21, 2013 after the clo...

Nordson Corporation Announces Earnings Release and Webcast for Second Quarter Fiscal Year 2013

WESTLAKE, Ohio, May 2, 2013 (GLOBE NEWSWIRE) -- Nordson Corporation (Nasdaq:NDSN) today announced it will release second quarter fiscal year 2013 earnings on Thursday, May 23, 2013 after the close of...

Drugs and Medications [ 6 Associated Drugs and Medications listed on BioPortfolio]

Citranatal [Mission Pharmacal Company]

CitraNatalB-CalmRx Prenatal Vitamin with two 25 mg each Vitamin B tablets

Citranatal harmony [MISSION PHARMACAL COMPANY]

CitraNatal Harmony Rx Prenatal Vitamin Gel Cap

Citranatal assure [Mission Pharmacal Company]

CitraNatalAssure Rx Prenatal Vitamin Tablet and 300 mg DHA Capsule

Diclofenac sodium [Physicians Total Care, Inc.]

Diclofenac sodium [Physicians Total Care, Inc.]

PubMed Articles [ 75 Associated PubMed Articles listed on BioPortfolio]

Congress highlights saturday, march 19, to thursday, march 24, 2011.

Congress awards sunday, march 20, to thursday, march 24, 2011.

Congress business sessions tuesday, march 22, to thursday, march 24, 2011.

Congress education sessions saturday, march 19, to thursday, march 24, 2011.

Congress general sessions sunday, march 20, to thursday, march 24, 2011.

Clinical Trials [ 42 Associated Clinical Trials listed on BioPortfolio]

Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma

To investigate safety and antitumor activity of SGN-30 in patients with Hodgkin's Disease and anaplastic large cell lymphoma (ALCL). As of March 22, 2005, interim analysis of the Hodgkin'...

Comparative Study of Laparoscopic Versus Open Operations for Colon Cancer

The purpose of this study is to compare the short and long term outcomes of people who have colon cancers removed either by laparotomy (a large cut in the abdominal wall) or by a laparosco...

Vitamin D, C-reactive Protein and Insulin Resistance

Randomized, double blind, placebo-controlled clinical trial of vitamin D supplementation (cholecalciferol, 4,000 IU/day for 6 months, in 104 postmenopausal women with type 2 diabetes melli...

A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

Study 20080008 was a PK sub-study to study 20050251[Japan 20050251A]. This PK protocol was amended 20-March-2009 and is now a Phase 2 stand alone study. There are no sites participating i...

Safety and Efficacy of N8 in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543 and NN7008-3545

This trial is conducted in Asia, Europe, Japan, Oceania, North America and South America. The aim of this clinical trial is to investigate safety and efficacy of N8 in Haemophilia A patie...

Companies [ 198 Associated Companies listed on BioPortfolio]

Nordson MARCH

Nordson MARCH is the global leader in plasma processing technology for the semiconductor, printed circuit board (PCB), microelectronics, and medical & life science d...

Nordson Micromedics

For more than 25 years, Micromedics Inc. has been the leading developer and manufacturer of quality devices for the delivery of biomaterials. In addition to their proprietary deli...

Nordson Corporation

Nordson ASYMTEK

Nordson ASYMTEK, a world leader in precision automated fluid dispensing, conformal coating, and jetting technologies, designs and manufactures a full line of dispensing...

Sanofi Pasteur and March of Dimes

March of Dimes is the leading organization for pregnancy and baby health. With chapters nationwide and through its premier event, March for Babies, March of Dimes works to improve the health of babies...